| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |